Study | Population and sample Size | Variables in Model | Outcome |
---|---|---|---|
Aronson A et al, 2007 [91] | CABG patients n = 2381 | Age, preoperative CHF, prior MI, preexisting renal disease, intraoperative inotropes, intraoperative intra-aortic balloon pump, bypass time, pre-operative pulse pressure. | postoperative creatinine ≥2 mg/dL w/ increase ≥0.7 mg/dL from baseline or dialysis |
Basu RK et al. 2014 [29] | Pediatric critically ill patients n = 584 total in 4 cohorts | Vasopressor/inotrope use, invasive mechanical ventilation, percent fluid overload, change in creatinine clearance | KDIGO Stage 2/3 AKI |
Brown JR et al, 2007 [92] | CABG patients n = 8363 | Age, female, diabetes, peripheral vascular disease, CHF, hypertension, prior CABG, preoperative IABP, elevated WBC count | eGFR <30 ml/min/1.73 m2 |
Chawla LS et al, 2013 [37] Koyner JL et al, 2015 [93] | Critically ill patients n = 77 | Urine output measurement | Progression to AKIN stage III |
Chong E et al, 2012 [94] | Patients w/ eGFR <60 ml/min/1.73 m2 undergoing percutaneous coronary intervention n = 770 | Age, baseline eGFR, post-percutaneous coronary intervention, creatinine kinase, contrast volume | Contrast-induced nephropathy defined as 25 % or 0.5 mg/dL increase from baseline creatinine within 48 h after PCI |
Cruz DN et al. 2014 [95] | Critically ill patients n = 506 | Age, diabetes, cardiovascular disease, chronic kidney disease, hypertension, obesity, hyperbilirubinemia, cerebrovascular accident, AIDS, cancer, hypotension, high-risk surgery, nephrotoxin exposure, sepsis | AKI stage II and III defined by AKIN |
Demirjian S et al, 2012 [44] | Cardiac surgery patients n = 25,898 | gender, race, weight, pulmonary disease, CHF, diabetes, hypertension, type of surgery, previous cardiac surgery, emergency surgery, eGFR, albumin, bicarbonate, sodium, BUN, hemoglobin, platelet count, bilirubin, BMI, potassium, CPB time, intrasurgical transfusion or vasopressor, intrasurgical UOP | AKI requiring dialysis |
Forni LG et al. 2013 [39] | Patients admitted to an acute medical unit n = 3707 | Age, alertness scale, chronic kidney disease, congestive cardiac failure, diabetes, liver disease | AKI defined per KDIGO guidelines |
Gao et al. 2014 [96] | Coronary angiography intervention n = 3945 | Age, hypertension, acute MI, heart failure, use of intra-aortic balloon pump, decreased glomerular filtration rate, contrast volume | Increase in serum creatinine level |
Grimm JC et al 2015 [97] | Lung transplant n = 10,693 | Race, sarcoidosis, diabetes, weight, baseline renal function, Kanofsky performance score, previous ICU stay, ECMO, days on list, double transplant | AKI requiring dialysis |
Gurm HS et al. 2013 [98] | Patients undergoing a percutaneous coronary intervention n = 68,753 | age, weight, height, percutaneous coronary intervention status and indication, coronary artery disease presentation, cardiogenic shock, heart failure, ejection fraction, diabetes, CKMB, creatinine, hemoglobin, troponin I and T | ≥0.5 mg/dl increase in serum creatinine level from baseline, RRT receipt |
Ho J et al, 2012 [99] | Cardiac surgery patients n = 350 | Bypass time, baseline eGFR, euroSCORE, postoperative serum creatinine | AKI by AKIN criteria |
Hong SH et al. 2012 [100] | Living donor transplant recipients n = 429 | age, MELD, hypertension, platelet count, surgical time, packed red blood cell transfusion, lactate, furosemide dose, calcium chloride dose, phosphate level | Renal failure was defined according to RIFLE |
Kane-Gill et al. 2015 [38] | Elderly, critically ill n = 25,230 | age, gender, race, eGFR, heart failure, diabetes, hypertension, admission type (medical vs surgical), requirement for vasopressors or mechanical ventilation, sepsis, hypotension, nephrotoxic drugs. | AKI by KDIGO criteria |
Kim JM et al. 2014 [46] | Liver transplant recipients n = 153 | Hepatic encephalopathy, deceased donor liver donations, MELD score, intraoperative blood loss, and indication for liver transplantation | Patients who needed renal replacement therapy |
Kim MY et al, 2011 [101] | Isolated off-pump CABG patients n = 448 | High systolic blood pressure, low baseline eGFR, coronary angiography less than 7 days prior to surgery | AKI by AKIN criteria |
Kim WH et al. 2013 [102] | Aortic surgery with cardiopulmonary bypass n = 737 | Age, preoperative glomerular filtration, ejection fraction, operation time, intraoperative urine output, intraoperative furosemide use | AKI defined by RIFLE |
Kristovic D et al. 2015 [26] | Cardiac surgery patients n = 1056 | age, atrial fibrillation, CHF classification, previous cardiac surgery, creatinine, endocarditis, weight, gender, COPD, bypass | AKI stage by KDIGO AKI requiring dialysis |
Legrand M et al. 2013 [103] | Patients with endocarditis/ cardiac surgery with cardiopulmonary bypass n = 202 | Age, gender, pre-existing comorbidities, presence of shock, systemic emboli, NYHA classification, hemoglobin, baseline creatinine, need for mechanical ventilation, characteristics of infection/surgery, use of nephrotoxic agents | Development or progression of AKI in the 7 days following surgery. AKI defined per AKIN |
McMahon GM et al. 2013 [104] | Rhabdomyolysis within 3 days of admission n = 2371 | Age, female sex, cause of rhabdomyolysis, initial creatinine, creatinine phosphokinase, phosphate, calcium, and bicarbonate | Composite endpoint: Renal replacement therapy or mortality |
Medha et al. 2013 [41] | Trauma patients n = 4396 | hepatic dysfunction, urea, glucose, pulmonary dysfunction, severity of injury | serum creatinine level >2.0 mg/dL during the hospital stay |
Meersch M et al. 2014 [42] | Patients undergoing cardiac surgery with bypass n = 50 | Diabetes, severity of illness, ejection fraction, baseline serum creatinine, cross-clamp time, chronic obstructive pulmonary disease | AKI defined by RIFLE or AKIN together |
Mehran R et al, 2004 [22] | Patients undergoing percutaneous coronary interventions n = 8357 | Hypotension, intra-aortic balloon pump, congestive heart failure, age >75 years, anemia, diabetes, contrast volume, baseline creatinine or eGFR | Increase of ≥25 % or ≥0.5 mg/dL in pre-PCI serum creatinine at 48 h after PCI |
Mehta RH et al, 2006 [32] | CABG and/or valve surgery patients n = 449,524 | Preoperative creatinine, age, race, type of surgery, diabetes, shock, NYHA class, lung disease, recent myocardial infarction, prior cardiovascular surgery | AKI requiring dialysis |
Ng SY et al. 2014 [105] | Cardiac surgery patients n = 28,422 | obesity, infective endocarditis, cardiac procedure, preop creatinine, diabetes, urgency status, eGFR, CHF, age, cardiogenic shock, IABP use, bypass time, non-RBC blood product use, gender, reoperation for bleeding, hypercholesterolemia, hypertension, and respiratory disease | Increased creatinine > 200 mmol/L (2.26 mg/dL), ≥ 2x increase in creatinine over baseline, a new receipt for RRT |
Palomba H et al. 2007 [18] | Cardiac surgery patients n = 603 | age, serum creatinine, glucose, heart failure, combined surgeries, cardiopulmonary bypass time, cardiac output, central venous pressure | creatinine > 2.0 mg/dl or increase of 50 % above baseline |
Park MH et al. 2015 [106] | Living-donor liver transplant n = 538 | weight; diabetes, alcoholic liver disease, albumin <3.5 mg/dL, model for end-stage liver disease score, child-turcotte-pugh- estimated graft to recipient body weight ratio, operation details, calcineurin inhibitor use without mycophenolate | AKI as defined by RIFLE |
Rahmanian PB et al, 2011 [107] | Cardiac surgery patients n = 2511 | Pulmonary hypertension, preoperative renal dysfunction, bypass time, peripheral vascular disease, recent MI, atrial fibrillation, age, CHF, diabetes | AKI requiring dialysis |
Rodriguez et al. 2013 [108] | Severe Rhabdomyolysis n = 126 | Albumin, metabolic acidosis, prothrombin time, peak creatinine phosphokinase | RIFLE category |
Romano TG et al. 2013 [109] | Orthotopic liver transplant patients n = 114 | MELD | increase ≥ 0.3 mg/dL in serum creatinine |
Schneider DF et al, 2012 [110] | Critically ill burn patients n = 309 | age, sex, race, % body surface area burned, burn mechanism, intubation, inhalation injury, NROF, fraction of predicted Parkland resuscitation, early transfusion, weight, Charlson Score, drug abuse, smoker, number of preadmission medications, ACEI/ARB, diuretic, NSAIDs, methamphetamine, lowest hematocrit, potassium, sodium, pH, glucose, base deficit, lowest mean arterial pressure, temperature | AKI defined using RIFLE classification |
Simonini M et al. 2014 [111] | Elective cardiac surgery n = 802 | Age, gender, ejection fraction, hypertension, diabetes, renal function, reoperation cardiac surgery, surgery type | AKIN stage II/III AKI |
Slankamenac K et al. 2013 [112] | Liver surgery n = 549 | Need for blood transfusion, cirrhosis, oliguria, hepaticojejunostomy, use of colloids, use of diuretics, use of a bolus of catecholamines | R of RIFLE |
Soto K et al. 2013 [40] | Patients admitted from the emergency department n = 616 | Age, kidney susceptibility stage, chronic heart failure, hypertension, cardiovascular disease, and diabetes mellitus | New onset AKI per RIFLE |
Thakar CV et al, 2005 [17] | Cardiac surgery patients n = 31,677 | gender, CHF, ejection fraction, preop intra-aortic balloon pump, COPD, diabetes, previous cardiac surgery, emergency surgery, type of surgery, creatinine >1.2 | AKI requiring dialysis |
Tsai TT et al. 2014 [113] | Percutaneous coronary intervention n = 947,012 | Age, CKD, prior cardiovascular disease, acute coronary syndrome, cardiac arrest, anemia, CHF, intra-aortic balloon pump prior to procedure, cardiogenic shock | AKI defined by AKIN and AKI requiring dialysis |
Wang M et al. 2013 [114] | Patients with hemorrhagic fever (Hantann virus) n = 112 | age, gender, presence of shock, proteinuria, hematuria, platelet count, leukocyte | Required dialysis or increased serum creatinine ≥354 mmol/L |
Wang Y et al. 2013 [115] | Patients hospitalized with acute heart failure n = 1709 | Age, ≥ 3 previous hospital admissions for acute heart failure, systolic blood pressure <90 mmHg, serum sodium <130 mmol/L, heart functional class IV, proteinuria, SCr ≥ 104 mmol/L, intravenous furosemide dose ≥ 80 mg/day | increase in serum creatinine (SCr) of ≥26.4 mmol/L or ≥ 50 % within 48 h. |
Wijeysundera DN et al, 2007 [19] | Cardiac surgery patients n = 20,131 | Preoperative eGFR, diabetes, ejection fraction, previous cardiac surgery, procedures other than isolated CABG or ASD repair, non-elective procedure, preoperative intra-aortic balloon pump | AKI requiring dialysis |
Wong B et al. 2015 [116] | Cardiac surgery patients who developed AKI n = 2316 | Age, weight, preoperative creatinine, gender, preoperative intra-aortic balloon pump, ejection fraction, type of surgery, previous cardiac surgery, diabetes, COPD, cardiopulmonary bypass time, clamp time, pump time, number of bypass grafts | AKI Stage 1, stage 2, stage 3 |
Xu X et al, 2010 [117] | Liver transplant recipients n = 102 | age, MELD score, preoperative creatinine, BUN, sodium, and potassium, intraoperative UOP, intraoperative hypotension, intraoperative noradrenaline | Serum creatinine >1.5 mg/dl with an increase of 50 % above baseline and/or RRT |